Skip to content

AVATAR therapy in refractory auditory hallucinations.

Efficacy of Audio Visual Assisted Therapy Aid for Refractory hallucinations (AVATAR) in reducing auditory hallucinations in patients with schizophrenia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220226054121N1
Enrollment
40
Registered
2022-05-28
Start date
2022-09-23
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Schizophrenia

Interventions

Intervention 1: Intervention group: In the experimental group, patients undergo Audio Visual Assisted Therapy Aid for Refractory auditory hallucinations (AVATAR therapy) . This treatment consists of 6

Sponsors

University of social welfare and rehabilitation sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Experience annoying auditory hallucinations Age range 18 - 50 years Minimum Intermediate Education Sufficient command of Persian language The patient is able to identify a sound and the main hallucination (to reduce).

Exclusion criteria

Exclusion criteria: Refuse to take any medication Primary drug dependence There are serious thoughts of harming oneself or another

Design outcomes

Primary

MeasureTime frame
Duration and severity of resistant auditory hallucinations. Timepoint: Before intervention, after intervention and 1 month after intervention. Method of measurement: The Psychotic Symptom Rating Scale (PSYRAT).

Secondary

MeasureTime frame
Beliefs about voices. Timepoint: Before intervention, after intervention and 1 month after intervention. Method of measurement: The revised beliefs about voices questionnaire (BAVQ–R).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farhad Taremian

University of social welfare and rehabilitation sciences

taremian@gmail.com+98 21 2218 0045

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026